Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 6.67B | 6.00B | 5.18B | 4.46B | 4.43B |
Gross Profit | 4.93B | 4.47B | 3.86B | 3.35B | 3.18B |
EBITDA | 2.14B | 1.77B | 1.52B | 1.01B | 1.06B |
Net Income | 1.41B | 1.01B | 867.80M | 448.32M | 623.86M |
Balance Sheet | |||||
Total Assets | 15.97B | 15.83B | 14.83B | 13.17B | 12.61B |
Cash, Cash Equivalents and Short-Term Investments | 7.39B | 7.25B | 7.76B | 8.29B | 7.46B |
Total Debt | 1.77B | 2.68B | 3.45B | 0.00 | 0.00 |
Total Liabilities | 3.66B | 4.57B | 5.12B | 1.45B | 1.09B |
Stockholders Equity | 12.31B | 11.26B | 9.71B | 11.72B | 11.52B |
Cash Flow | |||||
Free Cash Flow | 1.27B | 931.47M | 893.83M | 783.04M | 897.94M |
Operating Cash Flow | 1.49B | 1.49B | 1.27B | 1.15B | 1.23B |
Investing Cash Flow | -1.12B | -1.29B | -2.86B | -367.76M | -402.20M |
Financing Cash Flow | -1.21B | -978.24M | 601.33M | 0.00 | 0.00 |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥7.73B | 9.47 | 3.59% | 26.37% | 39.14% | ||
80 Outperform | ¥23.97B | 6.80 | 0.73% | 7.38% | 25.90% | ||
77 Outperform | ¥20.43B | 12.69 | 2.48% | 11.06% | 39.41% | ||
77 Outperform | ¥10.68B | 16.22 | 1.80% | 18.97% | 10.09% | ||
61 Neutral | ¥3.04B | 20.87 | ― | 102.19% | -122.72% | ||
59 Neutral | €3.07B | 11.57 | -8.77% | 2.83% | 5.08% | -50.65% |